This topic contains a solution. Click here to go to the answer

Author Question: A patient with Parkinson's disease has been achieving effective symptom control with levodopa ... (Read 73 times)

dalyningkenk

  • Hero Member
  • *****
  • Posts: 598
A patient with Parkinson's disease has been achieving effective symptom control with levodopa (Dopar) but complains that the symptoms begin to return before it is time for the next dose. The drug just wears off, he states.
 
  The nurse should anticipate that the prescriber will order the pa-tient to a. take the levodopa at shorter dosing intervals.
  b. start taking a drug that reduces levodopa's half-life.
  c. take levodopa at longer dosing intervals.
  d. increase the dose to increase receptor binding.

Question 2

An obese patient is admitted to the unit. The blood glucose level is 379, urinalysis reveals glycosuria, blood pressure is 178/99, and the patient complains of muscle aches and weakness.
 
  The patient also exhibits a moon face and buffalo hump. The nurse recognizes these signs and symptoms as ___________________ ___ and anticipates ___________________ __. a. Graves' disease; treatment directed at the cause
  b. Addison's disease; administration of fludrocortisone
  c. Cushing's syndrome; treatment directed at the cause
  d. diabetes; insulin replacement therapy



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Dnite

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

A
Gradual loss (wearing off) develops near the end of the dosing interval and simply indicates that drug levels have declined to a subtherapeutic value. Wearing off can be minimized by shortening the dosing interval.
Giving a drug that prolongs levodopa's plasma half-life and giving a direct-acting dopamine agonist would be effective; giving a drug that reduces levodopa's half-life would not.
Levodopa should be taken at shorter dosing intervals, not longer ones.
Increasing the dose does not increase receptor binding. The availability of receptor binding makes a difference, and as does the drug's affinity for the receptor.

Answer to Question 2

C
Cushing's syndrome is manifested by obesity, hyperglycemia, glycosuria, hypertension, fluid and electrolyte disturbances, osteoporosis, muscle weakness, myopathy, hirsutism, a moon face, and a buffalo hump. Treatment is directed at the cause.
Graves' disease is not associated with the adrenal gland, but rather with the thyroid gland.
Addison's disease is manifested by weakness, emaciation, hypoglycemia, and increased pigmen-tation of the skin and mucous membranes.
Diabetes is manifested in many ways but not by a moon face or buffalo hump.




dalyningkenk

  • Member
  • Posts: 598
Reply 2 on: Jul 23, 2018
Gracias!


tranoy

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

For a complete list of videos, visit our video library